# COLUMVI
> **BLA761309** · Biologics License Application · Sponsor: GENENTECH INC · Approved 2023-06-15
## Drug
- **FDA Application Number:** BLA761309
- **Application type:** Biologics License Application
- **Brand name:** COLUMVI
- **Generic name:** GLOFITAMAB
- **Active ingredients:** GLOFITAMAB-GXBM
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Prescription
- **Sponsor:** GENENTECH INC
- **Manufacturer:** Genentech, Inc.
- **First approval:** 2023-06-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761309)
---
*MORVS · CC0 1.0*